Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock Hong Kong S.E.
Stocks
2196
CNE100001M79
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
23:15:01 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 18.20 HKD | +0.61% |
|
+6.42% | -6.70% |
| 09-14 | Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5% | MT |
| 09-08 | Fosun Pharma Gets China Approval for Phase 2/3 Vitiligo Drug Trial | MT |
| Market Cap | 56.9B 66.61B 8.49B 7.42B 6.98B 6.37B 11.95B 812B 11.95B 83.71B 32.3B 415B 31.89B 31.19B 1,337B | P/E 2026 * |
16.1x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 69.76B 81.67B 10.41B 9.1B 8.55B 7.8B 14.65B 995B 14.65B 103B 39.61B 508B 39.1B 38.24B 1,639B | EV / Sales 2026 * |
1.64x | EV / Sales 2027 * | 1.63x |
| Free-Float |
62.69% | Yield 2026 * |
1.92% | Yield 2027 * | 2.16% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2196 | Delayed | |
OTC Markets
| SFOSF | Delayed | |
|
Börse Stuttgart
| 08HH | Delayed | |
|
Tradegate
| 08HH | Real-time | |
|
Deutsche Boerse AG
| 08HH | Delayed | |
|
Boerse Muenchen
| 08HH | Real-time |
| 1 day | +0.83% | ||
| 1 week | +6.42% | ||
| Current month | +14.07% | ||
| 1 month | +8.57% | ||
| 3 months | +16.62% | ||
| 6 months | +1.62% | ||
| Current year | -6.70% |
| 1 week | 16.88 |  | 18.45 |
| 1 month | 15.72 | | 18.45 |
| Current year | 14.9 | | 22.18 |
| 1 year | 14.9 | | 26.86 |
| 3 years | 11.32 | | 29 |
| 5 years | 11.32 | | 44.55 |
| 10 years | 11.32 | | 82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 2025-06-23 |
Zhi Huang
DFI | Director of Finance/CFO | - | 2026-04-01 |
Wen Jie Zhang
PSD | President | 59 | 2023-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 1994-03-31 |
Yi Liu
BRD | Director/Board Member | 50 | 2025-12-01 |
Dong Hui Pan
BRD | Director/Board Member | 56 | 2020-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | +6.42% | - | - | 8.48B | |
| +0.45% | +3.00% | +55.00% | +112.54% | 1,038B | |
| -0.10% | +0.74% | +54.52% | +67.72% | 649B | |
| +0.28% | +0.82% | +19.15% | +73.63% | 467B | |
| -0.19% | +0.97% | +34.30% | +45.99% | 355B | |
| +0.28% | +2.30% | +18.47% | +26.67% | 269B | |
| +0.89% | +4.59% | +10.19% | +14.72% | 260B | |
| +4.34% | +9.21% | +43.44% | +53.25% | 213B | |
| +1.40% | +4.35% | +35.72% | +103.53% | 187B | |
| -0.46% | -6.20% | -32.46% | -59.65% | 176B | |
| Average | +0.74% | +2.04% | +26.48% | +48.71% | 401.68B | |
| Weighted average by Cap. | +0.48% | +2.08% | +36.36% | +67.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.53B 49.79B 6.35B 5.55B 5.21B 4.76B 8.93B 607B 8.93B 62.57B 24.15B 310B 23.84B 23.32B 999B | 43.27B 50.66B 6.46B 5.64B 5.3B 4.84B 9.09B 617B 9.09B 63.67B 24.57B 315B 24.26B 23.72B 1,017B |
| Net income | 3.83B 4.48B 571M 499M 469M 428M 803M 54.58B 803M 5.63B 2.17B 27.87B 2.14B 2.1B 89.86B | 4.24B 4.96B 633M 553M 520M 474M 890M 60.47B 890M 6.24B 2.41B 30.88B 2.38B 2.32B 99.56B |
| Net Debt | 12.86B 15.06B 1.92B 1.68B 1.58B 1.44B 2.7B 184B 2.7B 18.93B 7.3B 93.73B 7.21B 7.05B 302B | 14.06B 16.47B 2.1B 1.83B 1.72B 1.57B 2.95B 201B 2.95B 20.69B 7.98B 102B 7.88B 7.71B 330B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-22 | HK$18.20 | +0.61% | 1,287,809 |
| 26-09-22 | HK$18.09 | -1.09% | 4,004,311 |
| 26-09-21 | HK$18.29 | +5.60% | 6,855,193 |
| 26-09-18 | HK$17.32 | +0.99% | 5,534,653 |
| 26-09-17 | HK$17.15 | +0.06% | 3,616,098 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
- 2196 Stock
Select your edition
All financial news and data tailored to specific country editions
